Male Breast Cancer Summa Health System/Akron City Hospital Experience 1995-2007
NCT ID: NCT00773669
Last Updated: 2013-05-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
24 participants
OBSERVATIONAL
2008-10-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objectives are to:
* identify risk factors.
* evaluate stage and histology at the time of presentation.
* document treatment modalities and outcomes.
* analyze outcomes for comparison to historical data.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Male Breast Cancer: Understanding the Biology for Improved Patient Care
NCT01101425
Impact of Breast Magnetic Resonance Imaging (MRI) on Mastectomy Rates
NCT01166581
Understanding Male Breast Cancer: Salah Azaïz Cancer Institute Experience
NCT03240510
Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System
NCT06133647
Changes in Breast Density and Breast Cancer Risk in Women With Breast Cancer and in Healthy Women
NCT00445445
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
80 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Summa Health System
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gary Williams, MD
Role: PRINCIPAL_INVESTIGATOR
Summa Health System
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Male Breast Cancer
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.